Enliven Therapeutics
ELVN
#5218
Rank
A$1.80 B
Marketcap
$38.31
Share price
5.84%
Change (1 day)
80.00%
Change (1 year)

Enliven Therapeutics (ELVN) - Net assets

Net assets on the balance sheet as of June 2024 : A$0.45 B

According to Enliven Therapeutics's latest financial reports the company has A$0.45 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Enliven Therapeutics - Net assets on balance sheet (from 2021 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$A$0.36 B-419.71%
2022-12-31$-A$0.12 B91.4%
2021-12-31$-A$58.99 M123.85%
2020-12-31$-A$26.35 M